Abstrakt

Przypisy

• 1. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:American College of Chest Physicians Evidence-Based Clinical PracticeGuidelines. Chest, 2012; 141 (suppl. 2). http://journal.publications.chestnet.org/issue.aspx?issueid=23443 (01.05.2014)
  Google Scholar
• 2. Antonova N., Zvetkova E., Ivanov I., Savov Y.: Hemorheological changesand characteristic parameters derived from whole blood viscometryin chronic heroin addicts. Clin. Hemorheol. Microcirc., 2008; 39: 53-61
  Google Scholar
• 3. Bangsberg D.R., Rosen J.I., Aragon T., Campbell A., Weir L., Perdreau-RemingtonF.: Clostridial myonecrosis cluster among injectiondrug users: a molecular epidemiology investigation. Arch. Intern.Med., 2002; 162: 517-522
  Google Scholar
• 4. Beebe H.G., Scissons R.P., Salles-Cunha S.X., Dosick S.M., WhalenR.C., Gale S.S., Pigott J.P., Vitti M.J.: Gender bias in use of venousultrasonography for diagnosis of deep venous thrombosis. J. Vasc.Surg., 1995; 22: 538-542
  Google Scholar
• 5. Blane D., Wright P., Hood J.: Surveillance of blood stream infectionsin injecting drug users (IDUs) in a major teaching hospital fromJan-Dec 2005. J. Infect., 2007; 55: e72
  Google Scholar
• 6. Bounameaux H., de Moerloose P., Perrier A., Reber G.: Plasma measurementof D-dimer as diagnostic aid in suspected venous thromboembolism:an overview. Thromb. Haemost., 1994; 71: 1-6
  Google Scholar
• 7. Buckingham S., Maynert E.W.: The release of 5-hydroxytryptamine,potassium and amino acids from platelets. J. Pharmacol. Exp.Ther., 1964; 143: 332-339
  Google Scholar
• 8. Carroll J.: Attitudes to drug users according to age of staff. Prof.Nurse., 1996; 11: 401-402, 404
  Google Scholar
• 9. Ceriello A., Dello Russo P., Curcio F., Tirelli A., Giugliano D.: Depressedantithrombin III biological activity in opiate addicts. J. Clin.Pathol., 1984; 37: 1040-1042
  Google Scholar
• 10. Chokshi S.K., Miller G., Rongione A., Isner J.M.: Cocaine andcardiovascular disease: the leading edge. Cardiology, 1989; 111: 1-11
  Google Scholar
• 11. Cooke V.A., Fletcher A.K.: Deep vein thrombosis among injectingdrug users in Sheffield. Emerg. Med. J., 2006; 23: 777-779
  Google Scholar
• 12. Cornford C.S., Mason J.M, Inns F.: Deep vein thromboses in usersof opioid drugs: incidence, prevalence, and risk factors. Br. J. Gen.Pract., 2011; 61: e781-e786
  Google Scholar
• 13. Coughlin P.A., Mavor A.I.: Arterial consequences of recreationaldrug use. Eur. J. Vasc. Endovasc. Surg., 2006; 32: 389-396
  Google Scholar
• 14. Czarnecki M., Knysz B., Kwiatkowska W., Gasiorowski J., GladyszA.: Venous diseases in injecting drug users. 19th European Chapter Meeting of the International Union of Angiology. Final program andabstract book, 2010; PS 9-1: 81
  Google Scholar
• 15. Dawson D.: Vitamin K deficiency in injecting drug users. XXIIISTH Congress. J. Thromb. Haemost., 2009; 7: PP-MO-142
  Google Scholar
• 16. Dawson D.J., Peters L.: “Street” supplies of the anticoagulantdrug warfarin: a worrying new trend. Emerg. Med. J., 2006; 23: 488-489
  Google Scholar
• 17. Dawson D.J., Russell M., Mackway-Jones K., Shiach C.R., Peters L.:Management of injecting drug users (IDU) with deep vein thrombosis(DVT): a delphi study. XXth ISTH Congress, J. Thromb. Haemost.,2005; 3: P0476
  Google Scholar
• 18. Dwyer R., Topp L., Maher L., Power R., Hellard M., Walsh N., JaunceyM., Conroy A., Lewis J., Aitken C.: Prevalences and correlates ofnon-viral injecting-related injuries and diseases in a conveniencesample of Australian injecting drug users. Drug Alcohol Depend.,2009; 100: 9-16
  Google Scholar
• 19. European Monitoring Centre for Drugs and Drug Addiction(EMCDDA): Annual report on the state of the drugs problem in Europe,EMCDDA, Lisbon, 2013, http://www.emcdda.europa.eu/publications/annual-report/2010(12.12.2014)
  Google Scholar
• 20. Faeh F., Zimmerli W., Jordi M., Schoenenberger R.A.: Septic deepvenous thrombosis in intravenous drug users. Swiss Med. Wkly.,2002; 132: 386-392
  Google Scholar
• 21. Falagas M.E., Vardakas K.Z., Athanasiou S.: Intravenous heparinin combination with antibiotics for the treatment of deep veinseptic thrombophlebitis: a systematic review. Eur. J. Pharmacol.,2007; 557: 93-98
  Google Scholar
• 22. Fast D., Small W., Wood E., Kerr T.: The perspectives of injectiondrug users regarding safer injecting education delivered through asupervised injecting facility. Harm. Reduct. J., 2008; 5: 32
  Google Scholar
• 23. Fiddes R., Khattab M., Abu Dakka M., Al-Khaffaf H.: Patternsand management of vascular injuries in intravenous drug users: aliterature review. Surgeon, 2010; 8: 353-361
  Google Scholar
• 24. Finnie A., Nicolson P.: Injecting drug use: implications for skinand wound management. Br. J. Nurs., 2002; 11 (Suppl.): S17-S28
  Google Scholar
• 25. Fowler A., Mackay A.: Community-acquired methicillin-resistantStaphylococcus aureus pyomyositis in an intravenous drug user. J. Med.Microbiol., 2006; 55: 123-125
  Google Scholar
• 26. Fraser J.D., Anderson D.R.: Deep venous thrombosis: recent advancesand optimal investigation with US. Radiology, 1999; 211: 9-24
  Google Scholar
• 27. Galante A., De Luca A., Pietroiusti A., Tiratterra F., BenincasaE., Domenici B., Baldelli C., Valenzi C.: Effects of opiates on bloodrheology. J. Toxicol. Clin. Toxicol., 1994; 32: 411-417
  Google Scholar
• 28. Garcia-Sevilla J.A., Ugedo L., Ulibarri I., Gutierrez M.: Plateletalpha 2-adrenoceptors in heroin addicts during withdrawal andafter treatment with clonidine. Eur. J. Pharmacol., 1985; 114: 365-374
  Google Scholar
• 29. Gebhard C., Breitenstein A., Akhmedov A., Gebhard C.E., CamiciG.G., Luescher T.F., Tanner F.C.: Amphetamines induce tissue factorand impair tissue factor pathway inhibitor: role of dopamine receptortype 4. Eur. Heart J., 2010; 31: 1780-1791
  Google Scholar
• 30. Haber P.S., Demirkol A., Lange K., Murnion B.: Management of injectingdrug users admitted to hospital. Lancet, 2009; 374: 1284-1293
  Google Scholar
• 31. Hakeem M.J., Bhattacharyya D.N.: Septic deep venous thrombophlebitisand distant emboli in injecting drug users – treatmentexperience and outcome. J. R. Coll. Physicians Edinb., 2007; 37: 293-299
  Google Scholar
• 32. Heit J.A., Mohr D.N., Silverstein M.D., Petterson T.M., O’FallonW.M., Melton L.J. 3rd: Predictors of recurrence after deep veinthrombosis and pulmonary embolism: a population-based cohortstudy. Arch. Intern. Med., 2000; 160: 761-768
  Google Scholar
• 33. Hughes C.A., Freitas A., Miedzinski L.J.: Interaction between lopinavir/ritonavirand warfin. CMAJ, 2007; 14: 177: 357-359
  Google Scholar
• 34. Irish C., Maxwell R., Dancox M., Brown P., Trotter C., Verne J.,Shaw M.: Skin and soft tissue infections and vascular disease amongdrug users, England. Emerg. Infect. Dis., 2007; 13: 1510-1511
  Google Scholar
• 35. Kaufman M.J., Siegel A.J., Mendelson J.H., Rose S.L., Kukes T.J.,Sholar M.B., Lukas S.E., Renshaw P.F.: Cocaine administration induceshuman splenic constriction and altered hematologic parameters. J.Appl. Physiol., 1998; 85: 1877-1883
  Google Scholar
• 36. Kearon C.: Natural history of venous thromboembolism. Circulation,2003; 107 (Suppl.1): I-22-I-30
  Google Scholar
• 37. Kelly J., Rudd A., Lewis R.R., Hunt B.J.: Plasma D-dimers in thediagnosis of venous thromboembolism. Arch. Intern. Med., 2002;162: 747-756
  Google Scholar
• 38. Klein S.K., Slim E.J., de Kruif M.D., Keller T.T., ten Cate H., vanGorp E.C., Brandjes D.P.: Is chronic HIV infection associated with venousthrombotic disease? A systematic review. Neth. J. Med., 2005;63: 129-136
  Google Scholar
• 39. Kugelmass A.D., Oda A., Monahan K., Cabral C., Ware J.A.:Activation of human platelets by cocaine. Circulation, 1993; 88:876-883
  Google Scholar
• 40. Labropoulos N., Giannoukas A.D., Leon M., Kalodiki E., WyattM., Gupta S.D., Nicolaides, A.N.: Complications after intravenousdrug abuse and the diagnostic value of color flow duplex scanning.J. Vasc. Technol., 1996; 20: 27-28
  Google Scholar
• 41. Lawson W.L., Robertson L.T., Tait R.C.: Management of intravenousdrug users with venous thromboembolism. Br. J. Haematol.,2003; 121: 19
  Google Scholar
• 42. Lee A.Y., Ginsberg J.S.: Laboratory diagnosis of venous thromboembolism.Baillieres Clin. Haematol., 1998; 11: 587-604
  Google Scholar
• 43. Lisse J.R., Davis C.P.: Thurmond-Anderle M.E.: Upper extremitydeep venous thrombosis: increased prevalence due to cocaine abuse.Am. J. Med., 1989; 87: 457-458
  Google Scholar
• 44. Liu H.S., Kho B.C., Chan J.C., Cheung F.M., Lau K.Y., Choi F.P., WuW.C., Yau T.K.: Venous thromboembolism in the Chinese population– experience in a regional hospital in Hong Kong. Hong Kong Med.J., 2002; 8: 400-405
  Google Scholar
• 45. Mackenzie A.R., Laing R.B.S., Douglas J.G., Greaves M., SmithC.C.: High prevalence of iliofemoral venous thrombosis with severegroin infection among injecting drug users in North East Scotland:succesful use of low molecular weight heparin with antibiotics.Postgrad. Med. J., 2000; 76: 561-565
  Google Scholar
• 46. Maliphant J., Scott J.: Use of the femoral vein (‘groin injecting’)by a sample of needle exchange clients in Bristol, UK. Harm Reduct.J., 2005; 2: 6
  Google Scholar
• 47. Martin C.A., Wijesurendra R.S., Borland C.D., Karas J.A.: Femoralvein thrombophlebitis and septic pulmonary embolism due toa mixed anaerobic including Solobacterium moorei: a case report. J.Med. Case Rep., 2007; 1: 40
  Google Scholar
• 48. Masoomi M., Ramezani M.A., Shahriari S., Shahesmaeeli A., MirzaeepourF.: Is opium addiction a risk factor for deep vein thrombosis?A case-control study. Blood Coagul. Fibrynolysis, 2010; 21:109-112
  Google Scholar
• 49. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., HickmanM., Strathdee S.A., Wodak A., Panda S., Tyndall M., Toufik A., MattickR.P.: Global epidemiology of injecting drug use and HIV amongpeople who inject drugs: a systematic review. Lancet, 2008; 372:1733-1745
  Google Scholar
• 50. McColl M.D., Tait R.C., Greer I.A., Walker I.D.: Injecting drug useis a risk factor for deep vein thrombosis in women in Glasgow. Br. J.Haematol., 2001; 112: 641-643
  Google Scholar
• 51. Mcdermott N., Ahluwalia N.: Lifetime prevalence of deep veinthrombosis among heroin users in Rotherham. 2005. http://www.addiction-ssa.org/2005/NAhluwaliaPoster.pdf (01.05.2014)
  Google Scholar
• 52. Mohammadzadeh M.A., Hossain-Akbar M., Ejtemaee-Mehr S.:Vascular lesions in intravascular drug abusers in Guilan, North ofIran. Arch. Iran. Med., 2007; 10: 522-524
  Google Scholar
• 53. Moliterno D.J., Lange R.A., Gerard R.D., Willard J.E., Lackner C.,Hillis L.D.: Influence of intranasal cocaine on plasma constituentsassociated with endogenous thrombosis and thrombolysis. Am. J.Med., 1994; 96: 492-496
  Google Scholar
• 54. Pieper B., DiNardo E.: Reasons for nonattendance for the treatmentof venous ulcers in an inner-city clinic. J. Wound OstomyContinence Nurs., 1998; 25: 180-186
  Google Scholar
• 55. Pieper B., Templin T.: Lower extremity changes, pain, and functionin injection drug users. J. Subst. Abuse Treat., 2003; 25: 91-97
  Google Scholar
• 56. Prandoni P., Lensing A.W., Cogo A., Cuppini S., Villalta S., CartaM., Cattelan A.M., Polistena P., Bernardi E., Prins M.H.: The long–term clinical course of acute deep venous thrombosis. Ann. Intern.Med., 1996; 125: 1-7
  Google Scholar
• 57. Ramasamy K.A., Draycott P., Henstock D., Logan E.: Treatmentof deep venous thrombosis in intravenous drug abusers: a districtgeneral hospital experience. Br. J. Haematol., 2003; 121: 1-40
  Google Scholar
• 58. Rinder H.M., Ault K.A., Jatlow P.I., Kosten T.R., Smith B.R.: Plateletα-granule release in cocaine users. Circulation, 1994; 90: 1162-1167
  Google Scholar
• 59. Rosli N.M., McGoldrick C., McEwen R., Laing R.B., Mackenzie A.R.,Douglas J.G.: Bacteraemias in injecting drug users – the Grampianexperience. J. Infection, 2007; 55: e71
  Google Scholar
• 60. Roszler M.H., McCarroll K.A., Donovan K.R., Rashid T., Kling G.A.:The groin hit: complications of intravenous drug abuse. Radiographics,1989; 9: 487-508
  Google Scholar
• 61. Sadosty A.T., Goyal D.G., Boie E.T., Chiu C.K.: Emergency departmentD-dimer testing. J. Emerg. Med., 2001; 21: 423-429
  Google Scholar
• 62. Saif M.W., Bona R., Greenberg B.: AIDS and thrombosis: retrospectivestudy of 131 HIV-infected patients. AIDS Patient Care STDS,2001: 15: 311-320
  Google Scholar
• 63. Salmon A.M., Dwyer R., Jauncey M., van Beek I., Topp L., MaherL.: Injecting-related injury and disease among clients of a supervisedinjecting facility. Drug Alcohol Depend., 2009; 101: 132-136
  Google Scholar
• 64. Schulz S., Beckenbach C., Philipp M., Hengstmann J.: Color codedduplex sonography of inguinal vessels in i.v. drug addicts. Vasa,2002; 31: 7-13
  Google Scholar
• 65. Scott J., Kennedy E.J., Winfield A.J., Bond C.: Investigation intoeffectiveness of filters for use by intravenous drug users. Int. J. DrugPolicy, 1998; 9: 181-186
  Google Scholar
• 66. Scott T.E., LaMorte W.W., Gorin D.R., Menzoian J.O.: Risk factorsfor chronic venous insufficiency: a dual case-control study. J. Vasc.Surg., 1995; 22: 622-628
  Google Scholar
• 67. Senbanjo R., Tipping T., Hunt N., Strang J.: Injecting drug usevia femoral vein puncture: preliminary findings of a point-of-careultrasound service for opioid-dependent groin injectors in treatment.Harm. Red. J., 2012; 9: 6
  Google Scholar
• 68. Stein M.D., Sobota M.: Injection drug users: hospital care andcharges. Drug Alcohol Depend., 2001; 64: 117-120
  Google Scholar
• 69. Strathdee S.A., Stockman J.K.: Epidemiology of HIV among injectingand non-injecting drug users: current trends and implicationsfor interventions. Curr. HIV/AIDS Rep., 2010; 7: 99-106
  Google Scholar
• 70. Syed F.F., Beeching N.J.: Lower-limb deep-vein thrombosis ina general hospital: risk factors, outcomes and the contribution ofintravenous drug use. Q.J.M., 2005; 98: 139-145
  Google Scholar
• 71. Tassies D., Freire C., Pijoan J., Maragall S., Monteagudo J.,Ordinas A., Reverter J.C.: Pharmacogenetics of acenocoumarol:cytochrome P450 CYP2C9 polymorphisms influence dose requirementsand stability of anticoagulation. Haematologica, 2002; 87:1185-1191
  Google Scholar
• 72. Togna G., Tempesta E., Togna A.R., Dolci N., Cebo B., CaprinoL.: Platelet responsiveness and biosynthesis of thromboxane andprostacyclin in response to in vitro cocaine treatment. Haemostasis,1985; 15: 100-107
  Google Scholar
• 73. White R.H.: The epidemiology of venous thromboembolism.Circulation, 2003; 107 (Suppl.1): I-4-I-8
  Google Scholar
• 74. Williams K., Abbey E.: Knowledge of deep vein thrombosisamong intravenous drug misusers. Psych. Bulletin, 2006; 30: 263-265
  Google Scholar
• 75. Williams P.G., Ansell S.M., Milne F.J.: Illicit intravenous drug usein Johannesburg – medical complications and prevalence of HIV infection.S. Afr. Med. J., 1997; 87: 889-891
  Google Scholar
• 76. Yegane R.A., Salehi N.A., Ghaseminegad A., Bahrami F., BashashatiM., Ahmadi M., Hojjati M.: Surgical approach to vascular complicationsof intravenous drug abuse. Eur. J. Vasc. Endovasc. Surg.,2006; 32: 397-401
  Google Scholar
• 77. Yeh R.F., Gaver V.E., Patterson K.B., Rezk N.L., Baxter-MeheuxF., Blake M.J., Eron J.J.Jr, Klein C.E., Rublein J.C., Kashuba A.D.: Lopinavir/ritonavirinduces the hepatic activity of cytochrome P450enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepaticand intestinal activity of CYP3A as measured by a phenotypingdrug cocktail in healthy volunteers. J. Acquir. Immune Defic. Syndr.,2006; 42: 52-60
  Google Scholar
• 78. Zierler B.K.: Ultrasonography and diagnosis of venous thromboembolism.Circulation, 2004; 109 (Suppl.1): I-9-I-14
  Google Scholar

Pełna treść artykułu